Eli Lilly and Novo Nordisk fell Wednesday after Roche released positive early-stage trial data on its oral weight-loss drug.

The post Eli Lilly, Novo Nordisk Fall As Roche Releases Weight-Loss Drug Data appeared first on Investor’s Business Daily.